AskNadia: Accidentally Injected 50 Units of NovoLog Insulin Instead of Lantus

Dear Nadia: I was going to watch a little TV before going to sleep I was wanting to wait up on my husband to get home from work. I grabbed my Lantus and took it in to the bedroom so I wouldn’t forget to take it before falling asleep. After getting all comfy in bed I thought I should just go ahead and take my

Read more

EU OKs Insulin Delivery Device for Type 2s

CeQur SA, a Swiss company that develops insulin delivery devices, has received approval to market its PaQ® insulin delivery device in Europe. The PaQ is a wearable device that delivers three days’ worth of basal, as well as on-demand bolus, insulin for people with type 2 diabetes. The device combines a disposable insulin-infuser reservoir with a reusable insulin monitor to function. CeQur spokesmen estimate that

Read more

Clinical Study Begins on Insulin Delivery Device for Type 2s

A clinical study has begun of a wearable device that continuously delivers basal insulin to people with type 2 diabetes. The device, PaQ®, is manufactured by CeQur SA, a Swiss company that has operations in Denmark and Massachusetts. Designed to provide three days of basal insulin delivery along with on-demand bolus insulin, the device incorporates a disposable insulin infuser reservoir attached to a reusable insulin

Read more

Type 1: FDA OKs Levemir for Two- to Five-Year-Olds

The US Food and Drug Administration has approved the use of Novo Nordisk’s Levemir basal insulin for type 1 children aged two to five years. The FDA decision makes Levemir (insulin detemir [rDNA origin]) the only basal insulin approved for use in this age group.Levemir, introduced to the US market in 2006, was previously approved for older children and adults with type 1 diabetes, as

Read more